CPEX Pharmaceuticals Affirms Recommendation That Stockholders Vote for Merger Agreement With FCB

CPEX Pharmaceuticals, Inc. CPEX today announced that its Board of Directors has completed its review of the unsolicited, non-binding letter received from Mangrove Partners on March 16, 2011 revising the terms of the potential alternative transaction involving a recapitalization of CPEX that Mangrove had originally proposed on March 14, 2011.